Ergoteles’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,839	Closed	-$412K	–	227
2023 Q2	$412K	Buy	22,839 +6,682	+41%	+$120K	0.02%	684
2023 Q1	$259K	Sell	16,157 -2,927	-15%	-$47K	0.01%	934
2022 Q4	$349K	Buy	+19,084	New	+$349K	0.01%	858